Dec 12, 2025
Tenaya Stock Plunges After $60 Million Equity Offering

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stock is trading lower on Friday, with a session volume of 42.39 million compared to the average volume of 3.51 million as per data from Benzinga Pro. • Tenaya Therapeutics stock is feeling bearish pressure. What’s pressuring…

Dec 12, 2025
FDA Approves Amgen’s Drug For Rare Muscle Disorder

The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen Inc.’s (NASDAQ:AMGN) Uplinza (inebilizumab-cdon) for generalized myasthenia gravis (gMG). The approval covers adult patients who are anti-acetylcholine receptor (AChR) and anti-muscle-specific tyrosine kinase (MuSK) antibody positive. gMG is a…

Dec 12, 2025
GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients

On Thursday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) supplemental New Drug Application for gepotidacin as an oral option for uncomplicated urogenital gonorrhoea. GSK stock is showing upward bias. What’s the outlook for GSK shares? Gonorrhoea is…

Dec 12, 2025
Why Broadcom’s Outlook Spooked Chip Stocks

Semiconductor stocks slid broadly on Friday after Broadcom Inc.’s (NASDAQ:AVGO) cautious profitability outlook punctured confidence in the AI-fueled chip rally. Nvidia Corp. (NASDAQ:NVDA), Advanced Micro Devices, Inc. (NASDAQ:AMD), Marvell Technology, Inc. (NASDAQ:MRVL), Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM), Micron Technology…